289 related articles for article (PubMed ID: 17891600)
1. Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.
Berentsen S; Beiske K; Tjønnfjord GE
Hematology; 2007 Oct; 12(5):361-70. PubMed ID: 17891600
[TBL] [Abstract][Full Text] [Related]
2. B-lymphocytes as targets for therapy in chronic cold agglutinin disease.
Berentsen S; Ulvestad E; Tjønnfjord GE
Cardiovasc Hematol Disord Drug Targets; 2007 Sep; 7(3):219-27. PubMed ID: 17896962
[TBL] [Abstract][Full Text] [Related]
3. Cold agglutinin disease: where do we stand, and where are we going?
Berentsen S; Malecka A; Randen U; Tjønnfjord GE
Clin Adv Hematol Oncol; 2020 Jan; 18(1):35-44. PubMed ID: 32511221
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia.
Berentsen S; Tjønnfjord GE
Blood Rev; 2012 May; 26(3):107-15. PubMed ID: 22330255
[TBL] [Abstract][Full Text] [Related]
5. Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease.
Berentsen S; Tjønnfjord GE; Brudevold R; Gjertsen BT; Langholm R; Løkkevik E; Sørbø JH; Ulvestad E
Br J Haematol; 2001 Oct; 115(1):79-83. PubMed ID: 11722415
[TBL] [Abstract][Full Text] [Related]
6. Cold agglutinin-mediated autoimmune hemolytic anemia in Waldenström's macroglobulinemia.
Berentsen S
Clin Lymphoma Myeloma; 2009 Mar; 9(1):110-2. PubMed ID: 19362990
[TBL] [Abstract][Full Text] [Related]
7. Cold agglutinin disease.
Berentsen S
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):226-231. PubMed ID: 27913484
[TBL] [Abstract][Full Text] [Related]
8. Severe autoimmune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder.
Jourdan E; Topart D; Richard B; Jourdan J; Sotto A
Leuk Lymphoma; 2003 May; 44(5):889-90. PubMed ID: 12802933
[TBL] [Abstract][Full Text] [Related]
9. Cold agglutinin-mediated autoimmune hemolytic anemia.
Berentsen S; Randen U; Tjønnfjord GE
Hematol Oncol Clin North Am; 2015 Jun; 29(3):455-71. PubMed ID: 26043385
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of rituximab in combination with oral cyclophosphamide in primary chronic cold agglutinin disease.
Vassou A; Alymara V; Chaidos A; Bourantas KL
Int J Hematol; 2005 Jun; 81(5):421-3. PubMed ID: 16158824
[TBL] [Abstract][Full Text] [Related]
11. [Chronic cold agglutinin disease].
Berentsen S
Tidsskr Nor Laegeforen; 1995 Feb; 115(4):473-5. PubMed ID: 7871504
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapy.
Tanaka H; Hashimoto S; Sugita Y; Sakai S; Takeda Y; Abe D; Takagi T; Nakaseko C
Int J Hematol; 2012 Oct; 96(4):501-5. PubMed ID: 22878940
[TBL] [Abstract][Full Text] [Related]
13. Rituximab in B-cell disorders other than non-Hodgkin's lymphoma.
Bosly A; Keating MJ; Stasi R; Bradstock K
Anticancer Drugs; 2002 Nov; 13 Suppl 2():S25-33. PubMed ID: 12710588
[TBL] [Abstract][Full Text] [Related]
14. [Autoimmune hemolytic anemia].
Karasawa M
Nihon Rinsho; 2008 Mar; 66(3):520-3. PubMed ID: 18326320
[TBL] [Abstract][Full Text] [Related]
15. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
[TBL] [Abstract][Full Text] [Related]
16. [Autoimmune hemolytic anemia].
Berentsen S; Sundic T; Hervig T; Tjønnfjord GE
Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2226-31. PubMed ID: 19898570
[TBL] [Abstract][Full Text] [Related]
17. [Rituximab in cold agglutinin disease].
Camou F; Viallard JF; Pellegrin JL
Rev Med Interne; 2003 Aug; 24(8):501-4. PubMed ID: 12888170
[TBL] [Abstract][Full Text] [Related]
18. Primary chronic cold agglutinin disease: a population based clinical study of 86 patients.
Berentsen S; Ulvestad E; Langholm R; Beiske K; Hjorth-Hansen H; Ghanima W; Sørbø JH; Tjønnfjord GE
Haematologica; 2006 Apr; 91(4):460-6. PubMed ID: 16585012
[TBL] [Abstract][Full Text] [Related]
19. Monotherapy with rituximab induces rapid remission of recurrent cold agglutinin-mediated hemolytic anemia in a patient with indolent lympho-plasmacytic lymphoma.
Cohen Y; Polliack A; Zelig O; Goldfarb A
Leuk Lymphoma; 2001; 42(6):1405-8. PubMed ID: 11911426
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of rituximab on primary cold agglutinin disease refractory to conventional therapy.
Mori A; Tamaru J; Sumi H; Kondo H
Eur J Haematol; 2002 Apr; 68(4):243-6. PubMed ID: 12071942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]